Qinecsa is thrilled to be exhibiting at the DIA Global Pharmacovigilance & Risk Management Strategies Conference, from January 27-29 2025 in Baltimore, MD. DIA’s Global
Thought leadership from Martin Holm-Petersen continues! Qinecsa’s Chief Strategy Officer contributes to PharmaVoice’s 2025 AI Trends Feature. In his contribution, Martin highlights how working with
Latest News – We’re pleased to share that our CEO Adam Sherlock has been featured on Pharmaceutical Technology‘s Drug Solutions podcast joining industry experts to
Veteran safety & PV leader Adam Sherlock will capitalize on Qinecsa’s deep domain expertise and comprehensive technology-powered solutions to pharma’s most complex product safety challenges
We are thrilled to announce that Qinecsa will be sponsoring the World Drug Safety Congress America 2024! THE LARGEST DRUG SAFETY EVENT IN THE WORLD
Pharmacovigilance is a critical component of the medicinal product lifecycle, focusing on ensuring the safety and efficacy of medicinal products from pre-clinical development through post-marketing
We are thrilled to announce that Qinecsa will be sponsoring the World Drug Safety Congress Europe 2024, marking our third year! EUROPE’S MOST EXCITING DRUG
Call centres are typically responsible for a high percentage of safety report entry. However, the nature of the reporting process means it is hard to
Understanding patient safety is an essential element of Patient Support Programs. However, traditional safety reporting systems involve multi-step manual processes that often result in compliance
Safety reporting is not a core focus for field-based staff, therefore inputting of reports is often completed at a later time. This means report entry
2 Leman Street,
London, E1W 9US
United Kingdom
Company number: 13916274
